Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- "Why are we excluded?" CUPE personal support workers to rally to be treated like every other profession in OntarioTORONTO, September 18, 2026--Personal support workers have been often treated as lesser workers in the health care system – often by management, and certainly by the government.
- Southern California University of Health SciencesSouthern California University of Health Sciences Earns 2026 Great Colleges to Work For Honor Roll Distinction for Fourth Consecutive YearEmployee-driven recognition highlights SCU for job satisfaction, compensation and benefits, professional development, supervisor effectiveness, and confidence in senior leadership — Southern California University of Health Sciences (SCU) has...
- Lakewood-Amedex Biotherapeutics Inc.Lakewood-Amedex Biotherapeutics Announces IRB Approval and Clinical Site Readiness to Initiate Phase 2a Clinical Trial of Nu-3 for the Treatment of Infected Diabetic Foot UlcersLakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials for infectious diseases called the Bisphosphocin® class,...
- Form 8.3 - Advanced Medical Solutions Group plc - Octopus InvestmentsFORM 8.3
- VulcanForms Inc.VulcanForms Appoints Jeff Hemenway Chief Revenue Officer to Accelerate GrowthManufacturing and growth veteran joins VulcanForms to lead global go-to-market operations as the company scales its digital-first manufacturing platform for commercial, medical, aerospace, defense and industrial customers BOSTON, Sept. 18, 2026 -- VulcanForms, an MIT-born,...
- XORTX Therapeutics Inc.XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market OpportunityInvestigational New Drug application planned for submission to the U.S. FDA in the fourth quarter of 2026, advancing the Company’s regulatory path toward NDA filing for gout program XRx-026
- Angle HealthAngle Health Raises $600 Million at a $2.7 Billion Valuation to Continue Expanding Affordable Healthcare Access for Small BusinessesSAN FRANCISCO, September 18, 2026--Angle Health, the first AI-native healthcare benefits platform, today announced a $600 million equity financing at a $2.7 billion valuation, consisting of a $200 million Series C financing and a $400 million tender offer. The round, led by Vitruvian Partners with participation from new investor Town Hall Ventures and existing investors Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator, is expected to close later this month.
- Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein ImmediatelyLead Plaintiff Deadline November 2, 2026
- Children's Hospital Los AngelesChildren’s Hospital Los Angeles Earns Top National and Global Pediatric Hospital Honors from U.S. News & World Report and NewsweekLOS ANGELES, September 18, 2026--CHLA ranks among the nation’s top 10 pediatric hospitals and No. 1 in California, and is ranked No. 5 worldwide in pediatrics by Newsweek.
- Penelope HealthPenelope Health Announces Partnership with Thoreau to Accelerate its Platform for Real-Time Policy IntelligenceNEW YORK, September 18, 2026--Penelope Health ("Penelope"), a real-time provider and payer policy intelligence platform, today announced a partnership with Thoreau, which is building healthcare’s foundational compute, rules, and research infrastructure platform, to create a shared infrastructure layer for real-time payments and clinical rules. Thoreau, along with other investors, has committed $100 million in funding to Penelope. Penelope will use the capital to create new products that bring ad
- PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health HoldingsPMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdin
- LifeVantage CorporationLifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Terrence Moorehead, Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the upcoming WTR Virtual Insights Conference on Wednesday, September 23, 2026.